Literature DB >> 27889039

Epidemiology of Anal Canal Cancer.

Valerie M Nelson1, Al B Benson2.   

Abstract

Anal cancer is a rare malignancy, although its incidence has been increasingly in recent decades. This article discusses risk factors for anal cancer and how these risk factors affect the changing demographics of this disease. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anal canal; Epidemiology; HIV; HPV

Mesh：

Substances：

Year:  2017        PMID： 27889039     DOI： 10.1016/j.soc.2016.07.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  19 in total

1.  Delayed Diagnosis of Anal Cancer.

Authors:  Katherine Bingmer; Asya Ofshteyn; Sharon L Stein; Emily Steinhagen
Journal:  J Gastrointest Surg       Date:  2019-08-16       Impact factor: 3.452

2.  Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population.

Authors:  Bernhard Fankhaenel; Joerg Zimmer; Dorothea Bleyl; Eric Puffer; Andreas Schreiber; Thomas Kittner; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2019-10-22       Impact factor: 2.571

Review 3.  Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).

Authors:  Eleonor Rivin Del Campo; Oscar Matzinger; Karin Haustermans; Didier Peiffert; Robert Glynne-Jones; Kathryn A Winter; Andre A Konski; Jaffer A Ajani; Jean-François Bosset; Jean-Michel Hannoun-Levi; Marc Puyraveau; A Bapsi Chakravarthy; Helen Meadows; John Northover; Laurence Collette; Melissa Christiaens; Philippe Maingon
Journal:  Eur J Cancer       Date:  2019-09-28       Impact factor: 9.162

4.  The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study.

Authors:  Victoria Umutoni; Matthew B Schabath; Alan G Nyitray; Timothy J Wilkin; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Staci L Sudenga
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

5.  Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.

Authors:  M S Agarwal; K E Hitchcock; C G Morris; T J George; W M Mendenhall; R A Zlotecki
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

6.  Comparison of definitive chemoradiation with 5-fluorouracil versus capecitabine in anal cancer.

Authors:  Yoanna Pumpalova; Margaret M Kozak; Rie von Eyben; Pamela Kunz; George Fisher; Daniel T Chang; Sigurdis Haraldsdottir
Journal:  J Gastrointest Oncol       Date:  2019-08

7.  Cross comparison of AmpFire HPV genotyping assay and Roche human papillomavirus (HPV) linear array for HPV genotyping of anal swab samples.

Authors:  Kaleigh A Connors; Stephen Abbott; Kamwing Jair; Jason Daniels; Madison Lintner; David Klein; Avery Wimpleberg; Jeanne A Jordan
Journal:  J Virol Methods       Date:  2021-02-27       Impact factor: 2.623

8.  Comparing Age at Cancer Diagnosis between Hispanics and Non-Hispanic Whites in the United States.

Authors:  Humberto Parada; Andrew H Vu; Paulo S Pinheiro; Caroline A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-28       Impact factor: 4.254

9.  Do Temporal Trends in Cancer Incidence Reveal Organ System Connections for Cancer Etiology?

Authors:  Wan Yang; Mary Beth Terry
Journal:  Epidemiology       Date:  2020-07       Impact factor: 4.860

10.  International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.

Authors:  Sheela Rao; Francesco Sclafani; Cathy Eng; Richard A Adams; Marianne G Guren; David Sebag-Montefiore; Al Benson; Annette Bryant; Clare Peckitt; Eva Segelov; Amitesh Roy; Matt T Seymour; Jack Welch; Mark P Saunders; Rebecca Muirhead; Peter O'Dwyer; John Bridgewater; Shree Bhide; Rob Glynne-Jones; Dirk Arnold; David Cunningham
Journal:  J Clin Oncol       Date:  2020-06-12       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.